Harvard Bioscience (HBIO) Earnings Date, Estimates & Call Transcripts

$3.69
-0.03 (-0.81%)
(As of 04/24/2024 ET)

Earnings Summary

Latest
Earnings Date
Mar. 7Estimated
Actual EPS
(Mar. 7)
$0.01 Missed By -$0.02
Consensus EPS
(Mar. 7)
$0.03
Skip Charts & View Estimated and Actual Earnings Data

HBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Harvard Bioscience Analyst EPS Estimates

Current Year EPS Consensus Estimate:$0.14 EPS

HBIO Earnings Date and Information

Harvard Bioscience last announced its earnings results on March 7th, 2024. The medical instruments supplier reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.03 by $0.02. The firm earned $28.15 million during the quarter, compared to analyst estimates of $27.80 million. Harvard Bioscience has generated ($0.08) earnings per share over the last year (($0.08) diluted earnings per share).

Harvard Bioscience Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/7/2024Q4 2023$0.03$0.01($0.02)$0.06$27.80 million$28.15 million
11/7/2023Q3 2023$0.02($0.02)($0.04)($0.01)$27.60 million$25.36 million
8/8/2023Q2 2023$0.03$0.03-$0.08$29.50 million$28.76 million
4/25/2023Q1 2023$0.03$0.04+$0.01$0.07$28.50 million$29.98 million
3/9/2023Q4 2022($0.02)$0.02+$0.04$0.08$30.20 million$28.43 million
11/8/2022Q3 2022$0.03($0.02)($0.05)$0.04$28.00 million$26.92 million
8/3/2022Q2 2022$0.01$0.02+$0.01($0.02)$30.10 million$29.21 million  
5/4/2022Q1 2022$0.03$0.02($0.01)$0.21$29.10 million$28.78 million    
3/8/2022Q4 2021$0.07$0.06($0.01)$0.10$32.65 million$33.06 million    
11/2/2021Q3 2021$0.06$0.06-$0.08$28.10 million$29.66 million    
8/5/2021Q2 2021$0.03$0.04+$0.01$0.09$27.40 million$29.20 million
5/6/2021Q1 2021$0.01$0.05+$0.04$0.08$25.30 million$26.99 million  

Harvard Bioscience Earnings - Frequently Asked Questions

When did Harvard Bioscience announce their last quarterly earnings?

Harvard Bioscience (NASDAQ:HBIO) last announced its quarterly earning data on Thursday, March 7, 2024. Learn more on HBIO's earnings history.

Did Harvard Bioscience beat their earnings estimates last quarter?

In the previous quarter, Harvard Bioscience (NASDAQ:HBIO) missed the analysts' consensus estimate of $0.03 by $0.02 with a reported earnings per share (EPS) of $0.01. Learn more on analysts' earnings estimate vs. HBIO's actual earnings.

How much revenue does Harvard Bioscience generate each year?

Harvard Bioscience (NASDAQ:HBIO) has a recorded annual revenue of $112.25 million.

How much profit does Harvard Bioscience generate each year?

Harvard Bioscience (NASDAQ:HBIO) has a recorded net income of -$3.41 million. HBIO has generated -$0.08 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:HBIO) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners